Insider Transactions in Q2 2022 at 10x Genomics, Inc. (TXG)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Sridhar Kosaraju |
BUY
Grant, award, or other acquisition
|
Direct |
2,120
+9.34%
|
-
|
|
Jun 15
2022
|
Mathai Mammen |
BUY
Grant, award, or other acquisition
|
Direct |
2,120
+43.58%
|
-
|
|
Jun 15
2022
|
Shehnaaz Suliman |
BUY
Grant, award, or other acquisition
|
Direct |
2,120
+43.58%
|
-
|
|
Jun 15
2022
|
John R Stuelpnagel |
BUY
Grant, award, or other acquisition
|
Direct |
2,120
+0.61%
|
-
|
|
Jun 15
2022
|
Kimberly J Popovits |
BUY
Grant, award, or other acquisition
|
Direct |
2,120
+43.58%
|
-
|
|
Jun 15
2022
|
Bryan E Roberts |
BUY
Grant, award, or other acquisition
|
Direct |
2,120
+43.58%
|
-
|
|
Jun 02
2022
|
Serge Saxonov Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
1,651
-39.9%
|
-
|
|
May 23
2022
|
Bradford Crutchfield Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
286
-0.29%
|
$13,728
$48.76 P/Share
|
|
May 23
2022
|
Benjamin J. Hindson |
SELL
Open market or private sale
|
Direct |
1,264
-0.67%
|
$60,672
$48.76 P/Share
|
|
May 23
2022
|
Justin J. Mc Anear |
SELL
Open market or private sale
|
Direct |
967
-1.61%
|
$46,416
$48.76 P/Share
|
|
May 23
2022
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,656
-0.27%
|
$127,488
$48.76 P/Share
|
|
May 16
2022
|
Sridhar Kosaraju |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+44.83%
|
$165,000
$11.48 P/Share
|
|
May 13
2022
|
Bradford Crutchfield Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
158
+0.16%
|
$6,320
$40.49 P/Share
|
|
May 13
2022
|
Justin J. Mc Anear |
BUY
Open market or private purchase
|
Direct |
158
+0.26%
|
$6,320
$40.49 P/Share
|